Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Sales Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Sales Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Net Sales Growth(%) 1.98-5.8612.442.857.86

What is the latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS is 1.98 based on Mar2024 Consolidated results.
Year Net Sales Growth
Mar20241.98
Mar2023-5.86
Mar202212.44
Mar20212.85
Mar20207.86

How is Net Sales Growth of GLENMARK PHARMACEUTICALS Trending?

Years Net Sales Growth % Change
Mar2024 1.98
Positive
Mar2023 -5.86
Negative
Mar2022 12.44
336.49
Mar2021 2.85
-63.74
Mar2020 7.86 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Net Sales Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹39,503.8 Cr -6.8% -12% 57.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,303.0 Cr -5.1% -9.4% 29.2% Stock Analytics
DIVIS LABORATORIES ₹143,389.0 Cr -7.3% -10.9% 53% Stock Analytics
CIPLA ₹114,645.0 Cr -1.4% -6.7% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹98,449.5 Cr -9% -14.4% 1.4% Stock Analytics
ZYDUS LIFESCIENCES ₹91,587.4 Cr -7% -5% 22.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-6.8%

-12%

57.4%

SENSEX

0.1%

-3.6%

7.9%


You may also like the below Video Courses